Novo Nordisk Us Research & Development, Inc.

MA · United States · Reporting entity ID 100000196804

Total reported 2019–2025

$3.75M

#803 of 2,960 reporting companies — 0% of all reported industry payments

$31K in general payments across 57 records, plus $3.72M in research funding across 230 records.

How it breaks down

General payments $30,771

Research funding $3,719,147

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.